How long does natural immunity produced by SARS-CoV-2 infection last?
Coronavirus disease 2019 (COVID-19) – caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a global […]
Coronavirus disease 2019 (COVID-19) – caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a global […] While the currently available coronavirus disease 2019 (COVID-19) vaccines have shown great efficacy in reducing the risk of hospitalization upon […] An encouraging analysis published in journal The Lancet Respiratory Medicine shows that hospital admissions and deaths due to the coronavirus […] A team of scientists from the USA has recently examined the risk of hospitalization in patients infected with more deadly […] Coronavirus disease 2019 (COVID-19) seroprevalence studies have been used since early in the pandemic to identify population immunity, rates of […] Since the coronavirus disease 2019 (COVID-19) vaccines have been available, healthcare workers have been prioritized to receive them and are […] Studies show that in transplant recipients, the humoral response to two doses of a COVID-19 vaccine is inferior to that […] The coronavirus disease 2019 (COVID-19) pandemic continues to persist as a result of the spread of newer variants of the […] Vaccine breakthrough infections (VBTs) occur in individuals, even after they have been vaccinated against a particular pathogen. With the radical […] A recent report published in the journal Cell Discovery has described the immunogenicity and protective efficacy of a novel coronavirus […]Coronavirus Disease COVID-19
How long does natural immunity produced by SARS-CoV-2 infection last?
Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine
Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland
Vaccination reduces risk of hospitalization from all SARS-CoV-2 variants
Study finds US pediatric COVID-19 cases are higher than expected
Diverse vaccine attitudes amongst UK healthcare workers suggest hesitancy may remain after vaccine acceptance
Study suggests two doses of COVID-19 vaccine may offer some protection for kidney transplant patients
Factors predicting vaccine hesitancy in India
Study shows SARS-CoV-2 breakthrough infections 18-fold lower than rate of infections among unvaccinated
Scientists develop a novel and potent SARS-CoV-2 RBD-homodimer vaccine
Copyright © 2024